Table 3.
Top 10 most significant associations between procedure delay (months) and adverse patient outcomes for cardiovascular and cancer-related diseases.
| ICD-10-CM | ICD-10-CM Description a | Procedure | Procedure Description b | Reduction c | N d | Outcome e | Beta/OR (95% CI) f | P-value |
|---|---|---|---|---|---|---|---|---|
| I25.110 | Atherosclerotic heart disease of native coronary artery with unstable angina pectoris | 33,517 | Coronary artery bypass | 24.5% | 273 | Hospital LOS | 0.09 (0.04 to 0.14) | 2.26 × 10-4 |
| C32.8 | Malignant neoplasm of overlapping sites of larynx | 15,734 | Muscle, myocutaneous, or fasciocutaneous flap | 47.2% | 247 | Hospital LOS | 0.16 (0.07 to 0.25) | 6.27 × 10-4 |
| I25.110 | Atherosclerotic heart disease of native coronary artery with unstable angina pectoris | 021009 W | Coronary artery bypass | 25.9% | 289 | Hospital LOS | 0.10 (0.04 to 0.15) | 8.25 × 10-3 |
| I25.82 | Total occlusion of coronary artery | 02100Z9 | Coronary artery bypass | 25.9% | 287 | Hospital LOS | 0.13 (0.05 to 0.22) | 2.42 × 10-3 |
| I48.3 | Typical atrial flutter | 02K83ZZ | Map conduction mechanism | 35.5% | 361 | Hospital LOS | 0.13 (0.04 to 0.21) | 3.25 × 10-3 |
| I49.01 | Ventricular fibrillation | 33,241 | Removal of implantable defibrillator | 32.6% | 224 | 6-month readmission | 0.99 (0.98 to 1.00) | 3.51 × 10-3 |
| I25.82 | Total occlusion of coronary artery | 027034Z | Dilation of Coronary Artery | 47.9% | 243 | 6-month readmission | 1.07 (1.02 to 1.13) | 3.66 × 10-3 |
| I12.0 | Hypertensive chronic kidney disease with stage 5 CKD or ESRD | 50,360 | Renal allotransplantation, implantation of graft | 65.2% | 878 | 6-month readmission | 1.03 (1.01 to 1.05) | 6.01 × 10-3 |
| I71.2 | Thoracic aortic aneurysm, without rupture | 33,863 | Ascending aorta graft | 46.7% | 253 | 6-month readmission | 1.02 (1.00 to 1.03) | 7.02 × 10-3 |
| I25.110 | Atherosclerotic heart disease of native coronary artery with unstable angina pectoris | 027035Z | Dilation of Coronary Artery | 47.9% | 70 | 6-month readmission | 0.17 (0.05 to 0.30) | 7.58 × 10-3 |
CKD = chronic kidney disease; ESRD = end stage renal disease.
Procedure descriptions are abbreviated from description.
Reporting percentage reduction in volume of respective procedure group between 2019 and 2020 timeframes
N represents the number of individuals included in analysis for each diagnosis-procedure pair from historical data.
Hospital LOS = hospitalization length of stay (days); 6-month readmission = any-cause inpatient or emergency room readmission within 6 months after discharge from a procedural inpatient stay.
Reported betas and odds ratios (OR) are per month of procedure delay. Beta and 95% CIs are derived from linear regression models with hospitalization length (days) as the outcome. OR and 95% CIs are derived from logistic regression models with mortality during hospitalization and readmission within 6 months as the outcomes. All models were adjusted for sex, race, age at first diagnosis, insurance type, and year that procedure was performed.